软组织肉瘤重建皮瓣手术的功能结局:带神经肌肉移植功能恢复的长期结果
回顾性分析20例软组织肉瘤广泛切除后行带神经肌肉移植重建的患者,采用MSTS评分评估功能。术后12个月平均MSTS评分为82.3,带蒂皮瓣与游离皮瓣重建患者分别为89.2和77.1。下肢、肿瘤≥5cm及游离皮瓣重建者的MSTS评分显著更低;带神经肌肉移植术后24个月评分(83.7)显著高于12个月(76.7)。
要点
- 下肢、肿瘤≥5cm及游离皮瓣重建者的MSTS评分显著更低。
- 带蒂皮瓣重建者12个月MSTS评分89.2,高于游离皮瓣的77.1。
- 带神经肌肉移植术后24个月MSTS评分83.7,显著高于12个月的76.7。
核心结论
- 功能结局与肿瘤部位、肿瘤大小及重建皮瓣类型显著相关(基于MSTS评分)。
- 带神经肌肉移植通过移植肌肉的充分恢复而非剩余肌肉的代偿性恢复,在术后24个月改善功能结局。
研究设计与样本
- 回顾性研究,20例患者因软组织肉瘤切除后行带神经肌肉移植联合带蒂或游离皮瓣进行功能重建。
- 13块背阔肌和1块股外侧肌联合股前外侧皮瓣以游离皮瓣形式移植,采用神经外膜-束膜缝合技术;6块背阔肌以带蒂皮瓣形式移植并保持神经连续性。
- 术后功能结局采用MSTS评分评估,上肢和下肢分别评估22例和24例患者。
主要发现
- 所有患者术后12个月平均MSTS评分为82.3。
- 带蒂皮瓣重建患者平均MSTS评分为89.2,游离皮瓣重建患者为77.1。
- 下肢、肿瘤大小≥5cm和游离皮瓣重建者的MSTS评分分别显著低于上肢、肿瘤大小<5cm和带蒂皮瓣重建者(P=0.02、0.37和0.008)。
- 带神经肌肉移植术后12个月MSTS评分为76.7,术后24个月显著升高至83.7(P=0.003)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Functional outcomes associated with prognostic factors and innervated muscle transplantation after wide soft tissue sarcoma resection remain unclear. We retrospectively examined the functional outcomes of reconstructive flap surgery for soft tissue sarcoma. Twenty patients underwent innervated muscle transplantation with pedicled or free flaps for functional reconstruction of resected muscles. Thirteen latissimus dorsi muscles and one vastus lateralis muscle combined with an anterolateral thigh flap were transferred as free flaps using the epi-perineural suture technique. Six latissimus dorsi muscles were transferred as pedicled flaps with neural continuity. Postoperative functional outcomes were assessed using the Musculoskeletal Tumor Society (MSTS) scores for the upper and lower extremities of 22 and 24 patients, respectively. The mean MSTS score for all patients was 82.3 at 12 months postoperatively. The mean scores for patients who underwent reconstruction with pedicled and free flaps were 89.2 and 77.1, respectively. The MSTS scores for the lower extremity, tumor size ≥5 cm, and free flap reconstruction were significantly lower than those for the upper extremity, tumor size <5 cm, and pedicled flap reconstruction (P = 0.02, 0.37, and 0.008, respectively). The postoperative MSTS score for innervated muscle transplantation was 76.7 at 12 months and was significantly higher (83.7) at 24 months (P = 0.003). Functional outcomes were significantly associated with tumor location, tumor size, and reconstructive flap type based on the MSTS scores. Innervated muscle transplantation improved functional outcomes at 24 months postoperatively via sufficient recovery of the innervated muscle, not the compensatory recovery of the remaining muscle.
引用
- Abe Y, Nagasaka S, Yamashita Y, et al. Functional outcomes of reconstructive flap surgery for soft tissue sarcoma: Long-term outcomes of functional restoration using innervated muscle transplantation. J Plast Reconstr Aesthet Surg. 2024. PMID: 38442511. doi:10.1016/j.bjps.2024.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。